Find your path to Ron
194 people in our graph share verified history with Ron — schools, employers, funds. One of them is your warm intro.
About
Ron Hunt is a Managing Director at New Leaf Venture Partners and one of the firm's founders, which he helped start in 2005. He focuses on early to late stage biopharmaceutical investments and has more than 25 years of experience investing in companies developing novel medicines. Before entering venture capital in 1998, he worked as a strategy and operations consultant to pharmaceutical and medical device clients, and held sales and marketing roles at Johnson & Johnson and SmithKline Beecham Pharmaceuticals. He holds an M.B.A. from The Wharton School and a B.S. from Cornell University.
Contact· self-published, not guessed
Invests in
Biotech
Experience
- New Leaf Venture PartnersManaging Directorcurrent2005 — present
- Sprout GroupPartner1998 — 2005
Skills & more
From Ron's professional profile.
Investments
Investor
Aspreva PharmaceuticalsCerexaDurata TherapeuticsHarpoon TherapeuticsIterum TherapeuticsNycomedPathology PartnersPhase ForwardRelypsaReViralSierra OncologyStromedix
Per the firm's website.
Colleagues at New Leaf Venture Partners
Frequently asked questions
- Who is Ron Hunt?
- Ron Hunt is a Managing Director at New Leaf Venture Partners and one of the firm's founders, which he helped start in 2005. He focuses on early to late stage biopharmaceutical investments and has more than 25 years of experience investing in companies developing novel medicines. Before entering venture capital in 1998, he worked as a strategy and operations consultant to pharmaceutical and medical device clients, and held sales and marketing roles at Johnson & Johnson and SmithKline Beecham Pharmaceuticals. He holds an M.B.A. from The Wharton School and a B.S. from Cornell University.
- Where does Ron Hunt work?
- Ron Hunt is Managing Director at New Leaf Venture Partners.
- What does Ron Hunt invest in?
- Ron Hunt invests in Biotech.
- What companies has Ron Hunt invested in?
- Investments tracked here include Aspreva Pharmaceuticals, Cerexa, Durata Therapeutics, Harpoon Therapeutics, Iterum Therapeutics, Nycomed, Pathology Partners, Phase Forward, Relypsa, ReViral, Sierra Oncology, Stromedix.
- Where did Ron Hunt go to school?
- Ron Hunt studied at The Wharton School (Master of Business Administration (MBA), Finance, General); Cornell University (Bachelor's Degree).
Same school
Also attended The Wharton School2,000
+ 1,994 more
Also attended Cornell University1,165
+ 1,159 more
